FDA — authorised 13 December 2017
- Application: BLA761072
- Marketing authorisation holder: PFIZER INC
- Local brand name: IXIFI
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 IXIFI in United States
FDA authorised IXIFI on 13 December 2017
Marketing authorisations
FDA
- Status: approved
IXIFI in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is IXIFI approved in United States?
Yes. FDA authorised it on 13 December 2017; FDA has authorised it.
Who is the marketing authorisation holder for IXIFI in United States?
PFIZER INC holds the US marketing authorisation.